Objective: This article will discuss the diagnosis of multiple sclerosis (MS), with particular attention to differentiating it from other diseases that can mimic it. Methods: We reviewed our own data, as well as the published experience on the differential diagnosis of MS and the most common errors leading to misdiagnosis. Results: Psychiatric diseases are mistaken for multiple sclerosis more often than any other conditions. Other multifocal illnesses or white-matter diseases are seldom confused with multiple sclerosis. Conclusion: Neurologists are most likely to misdiagnose multiple sclerosis in patients who have psychiatric problems or who have uncommon presentations of common diseases such as migraine, stroke, or neuropathies.
THE DIAGNOSIS OF MULTIPLE SCLEROSIS

Diagnostic Principles
The goal of this article is to review the diseases often confused with MS, rather than to discuss the proper way to diagnose MS. Nevertheless, while analyzing the differential diagnoses, a few words are appropriate about recognizing the disease itself to distinguish it from its mimics.
Although "official" requirements have been proposed for diagnosing MS, 1 these are of limited value for clinicians. Confirming or refuting MS is not done by following any "cookbook" or algorithm of the same tests on each and every patient. Instead, the diagnosis must be reached by careful examination of all the evidence both for and against the disease, and through questioning, examining, and testing; the neurologist must assemble this evidence until it is sufficiently compelling to find the patient "guilty" or "not guilty" of having MS. Even when great care is used, the diagnosis may be made in error (innocent people found guilty) or inappropriately dismissed (guilty people found innocent), and expert neurologists may disagree among themselves (hung juries). The inability to sometimes prove the diagnosis "beyond a shadow of a doubt," combined with the many nuances and pitfalls in the history, physical examination, and testing for MS, create the challenges of diagnosing MS. 2 Ultimately, the diagnosis will depend upon the extent to which the patient's overall picture has the expected findings typical of MS. 3, 4 
Red Flags and the Differential Diagnosis of MS
The diagnosis of MS should be questioned when clinical or laboratory findings are unexpected or atypical. These unusual features or "red flags" should raise suspicion that MS is not present. 5, 6 Rare patients with these red flags do have MS. However, most patients with other diseases will be identified by the presence of one or more of these atypical features. Table 1 is a summary of the findings which should alert the clinician to consider alternative diagnoses.
Prospective studies have shown that 2 factors most reliably identify patients who do not have MS. 6 The first is their lack of typical symptoms: no optic neuritis, Lhermitte sign, sensory level, neurogenic bladder, or other common deficits. The second is their lack of typical findings on magnetic resonance imaging (MRI) and CSF examination. Very few patients with MS have a normal MRI of the brain or normal CSF.
The "Abnormal" MRI
It has often been said that MS is a clinical diagnosis. This is not entirely true. It is unlikely a patient would be diagnosed with MS today (at least in Europe or North America) without undergoing MRI scanning. The introduction and refinement of MRI has changed the diagnostic process in MS, and most diagnostic criteria for MS rely heavily on interpretation of MRI. 1 This has also changed the misdiagnosis of MS. The most common reason for falsely attributing a patient's symptoms to MS is faulty interpretation of the MRI. 7 Signal abnormalities of one sort or another are so common on MRI as to be ubiquitous. Over-interpretation of such scans, falsely assuming the signal changes are MS, is the most common reason for misdiagnosing MS ( Table 2 ). The MRI, like other clinical features or laboratory tests, is simply one piece of evidence that must be placed in context to arrive at a correct diagnosis.
THE DIFFERENTIAL DIAGNOSIS OF MULTIPLE SCLEROSIS
Diagnostic Principles
MS is a disease disseminated in time and in space. Yet the differential of MS is almost never other diseases disseminated in time and in space. MS is a white-matter disease. Yet the differential of MS is almost never other white-matter diseases. Instead, the mimics of MS are the mundane conditions that most commonly affect the nervous system, such as migraine, stroke, and neuropathies. Of these, psychiatric illnesses dominate. Tables 3, 4 , and 5 list many of the diseases disseminated in time and in space that most standard texts present as the differential diagnoses of MS. 4, 8, 9 In fact, most of these are rare conditions seldom, if ever, seen in clinical practice. They are presented here for the sake of completeness, but their occurrence is so unusual that a positive test for these diseases may be more often a false positive than a true one. The misinterpretation of false-positive tests in MS is such a hazard that it deserves special caution.
The Hazards of Routine Screening: Beware of False Positives
The majority of patients presenting with a clinical picture typical of MS do in fact have MS. Mindlessly screening these patients with an unvarying battery of tests seldom generates a different diagnosis and more often leads to confusing false-positive results. 10 This is especially true of many tests ordered for the evaluation of other white-matter 
The Optic Neuritis Treatment Trial
The Optic Neuritis Treatment Trial (ONTT) is an instructive example of the pitfalls of screening tests in demyelinating disease. This study enrolled 457 patients with optic neuritis to determine the effectiveness of treatment and natural history of the disease. Patients were diagnosed with optic neuritis on clinical grounds: acute monocular visual loss with a field defect and an APD in an otherwise healthy young person. All patients were screened for other diseases that could mimic optic neuritis by having an MRI scan of the brain, CBC, metabolic profile, chest x-ray (to exclude sarcoid), FTA, and ANA. Thirty-one percent had a spinal tap. Only 2 out of the 457 patients proved to have a disease other than optic neuritis (1 with a pituitary tumor and 1 with an aneurysm). There were no patients whose diagnosis was changed by CSF or chest x-ray. Six had a positive FTA and 15 had an elevated ANA, but all of these were false positive. These screening tests thus confused the management of a number of patients, but none ever led to a different diagnosis. This was true whether patients came from rural or urban settings, the North or the South, academic centers or elsewhere.
11,12
Lyme Disease
Many authorities list Lyme disease high on the differential diagnosis of MS as a disease of young people capable of causing white-matter symptoms, sometimes relapsing and remitting, occasionally with MRI changes mimicking MS. In fact, the classic clinical and MRI picture of MS is almost never produced by Lyme disease, and routine screening in the absence of a specific indication will produce more false positives than true positives. In a study of MS patients in a Lyme-endemic area in New York, 283 consecutive patients with MS were screened for Lyme disease and 19 had positive Lyme serology. On further testing, including spinal tap with measurement of intrathecal antiborrelia antibodies, none of these 19 patients had Lyme disease.
13,14
Vitamin B12 Deficiency
A deficiency in vitamin B12 can lead to myelin damage, including a myelopathy, which can mimic MS. So vitamin B12 deficiency is commonly listed in the differential diagnosis of MS. Clinicians can again be led astray by screening tests, with studies showing decreased levels in up to 19% of MS patients. The reason for low serum vitamin B12 levels in MS patients is not clear, but these are usually false-positive values. Most MS patients labeled instead as deficient in B12 actually do have MS. [15] [16] [17] The various causes of vasculitis figure prominently in most lists of MS mimics. For example, systemic lupus erythematosus affects the central nervous system in approximately 40% of patients and can cause optic neuritis, myelopathy, and even INOs. In the CSF, IgG and oligoclonal bands can occur in 50%-70% of patients with CNS lupus, and MRI changes may be indistinguishable from those of MS. However, CNS involvement almost always occurs in the setting of unmistakable systemic disease so that lupus should seldom be confused with MS. Patients with CNS lupus usually have joint disease, rashes, alopecia, fevers, renal failure, and other stigmata of systemic lupus. Their spinal fluid usually also shows much higher protein and polymorphonuclear cell counts, more closely mimicking meningitis than MS. What is true of lupus holds for most other "connective tissue" inflammatory diseases as well, such as Sjögren syndrome, Behçet syndrome, and sarcoid. 18 Screening for these systemic, inflammatory, autoimmune, "collagen vascular" diseases is complicated by the presence of many immune-system changes in MS patients, including a high incidence of autoantibodies. But these are usually of no clinical significance. In one study, a positive ANA was found in 81% of MS patients. 19 Screening all suspected MS patients with an ANA will therefore yield too many false positives and too few cases of other inflammatory diseases.
Note that the same can be said for the lupus anticoagulant or antiphospholipid antibodies. These are also found in a high percentage of MS patients. Although their significance is still being debated, they are often of no clinical importance and merely confuse the diagnosis. 20 An abnormal screening laboratory test is simply one piece of evidence, and it must be combined with additional data and seasoned with clinical judgment before arriving at a definite diagnosis. Beware of diagnosing rare diseases (Lyme, vitamin deficiency, vasculitis, etc) even when their tests are positive.
Psychiatric Disease and Normal People
By far the most important disease confused with MS is psychiatric illness. 21, 22 Most patients referred to a neurologist for consideration of possible MS who do not have the disease instead suffer from some form of psychiatric disorder: somatization, hypochondriasis, malingering, depression, anxiety, or similar problems. In the few instances where the differential diagnosis of MS patients has been documented (as summarized in Table 6 ), psychiatric diseases emerged as the foremost problem. At the University of Colorado Multiple Sclerosis Center, 67% of patients referred for possible MS had some other condition, of which psychiatric disease was the most common. 22 Among patients referred to Dalhousie University's MS Unit from 1979 -1983 (before the availability of MRI), 13% did not have MS; most had psychiatric problems. 21 Prospective data from the Marshfield Multiple Sclerosis Center, a private, nonuniversity referral clinic, shows that 49% of the 142 patients evaluated for possible MS since May 2004 had other diseases. Seventy-five percent of these had psychiatric diagnoses. As shown in Table 6 , there are 7 conditions that accounted for almost all the alternative diagnoses at these 3 MS centers. None of these are other white-matter or inflammatory diseases disseminated in time or in space. Across diverse settings and referral patterns, over 3 decades, with or without MRI, the most common conditions mistaken for MS were psychiatric.
The second largest diagnostic category of "non-MS" patients is normal people describing everyday sensations that are misconstrued as abnormal. In one study, 32% of normal people between the ages of 20 and 45 reported transient neurologic symptoms, such as visual changes, loss of power, poor balance and coordination, and speech difficulty. 23 Care thus must be taken not to overemphasize the multitude of transient disturbances that plague all normal people: itches, twitches, "falling asleep" limbs, and fleeting visual obscurations.
Two useful features in distinguishing MS symptoms from normal or psychiatric problems are their anatomy and their time course. Psychiatric symptoms tend to be diffuse and difficult to explain anatomically, such as tingling in both hands and both feet simultaneously, numbness over the entire face, or generalized symptoms such as "feeling weak all over." In contrast, MS symptoms usually have a clear anatomic location. Even if an MS attack affects different foci in the nervous system, there will be distinct lesions (such as optic nerve plus spinal cord) rather than diffuse and general- The coexistence of known psychiatric problems is obviously another clue that a patient's neurologic symptoms might be psychiatric in origin. If a patient is known to be anxious or depressed or has a history of other psychosomatic problems, their current symptoms must be viewed with more suspicion. Studies have shown that when experienced clinicians conclude (after appropriate investigations) that a patient's symptoms are "nonorganic," they are seldom wrong. 24 Most of us correctly identify psychiatric findings. Nevertheless, people with psychiatric illness can also develop MS, and clinicians must guard against too superficial an evaluation of such patients.
HOW TO INFORM PATIENTS THAT THEY DO NOT HAVE MS
After a complete workup, often a diagnosis of MS, or any serious neurologic disorder, will not be established. The manner in which patients should be informed of this conclusion largely depends on their psychologic status. At one end of the spectrum are patients who, apart from understandable concern about the possibility of a disabling illness, are essentially normal psychologically. For these patients, the neurologist may explain the circumstances that led to the initial suspicion of MS (eg, over-reading of an MRI scan or misplaced concern about benign paresthesias) and the objective findings which have shown that MS is not present.
An intermediate class of patients consists of persons who have mild but persistent anxiety or mood disorder ("the worried well"), either constitutionally or because of the lingering suspicions on their part or the part of their neurologist that organic disease might be present. These patients will benefit from infrequent but regularly scheduled (eg, q. 3-6 months) return visits to the neurologist for reassurance and reevaluation. Eventually, these patients usually reach a point where they can be returned to the long-term supervision of their primary physician, always with the offer of a repeated neurologic assessment if needed.
At the other end of the psychologic spectrum are patients who have severe underlying mental disturbance and whose symptoms frequently evoke very negative emotions in physicians. For example, in an analysis of 300 new outpatient visits, Carson and colleagues 25 found that patients whose symptoms were not explained by organic disease were consistently rated as most difficult to help by neurologists. In this regard, O'Dowd 26 coined the term "heartsink patients" for persons who exasperate, defeat, and overwhelm their doctors by their behavior. Patients presenting with psychogenic symptoms often suffer from somatization disorder, anxiety disorder, hypochondriasis, depressive disorder, or an attachment to illness as a way of life.
Very few neurologists have the resources and skills to effectively manage patients with chronic psychogenic disorders. A major mistake for the neurologist in this circumstance is to attempt too much; for example, to try to cure the incurable by endeavoring to reverse an ingrained pattern of psychogenicity in one brief conversation. So if most patients with psychogenic symptoms reject immediate referral to a mental health professional and if the neurologist is usually not the best person to provide continued management, who is? The medical literature provides a consistent and positive answer to this question, namely, that the primary care physician, who deals with a high percentage of nonorganic or embellished complaints during each practice day, 27, 28 is usually well qualified by experience and training to help these patients. Several authoritative guidelines endorse short, frequent visits to a primary care physician for a program based on reassurance and support; limiting of testing and subspecialty referrals to those that truly are necessary; first-line treatment of depression and anxiety; and a gradual, nonthreatening shift of focus to consideration of stress and other psychologic factors. 29, 30 Eventually, psychogenic patients often reach the point that they will accept expert psychiatric referral. In summary, while the best hope for fundamental change over the long term lies with psychiatric treatment, in the short term, optimal management is usually based on supportive care with a primary care physician. Obvious exceptions to the recommendation for delayed psychiatric management are the rare patients who are psychotic or who are a danger to themselves or others.
CONCLUSION
The determination of MS is not made by following any set of diagnostic criteria. Rather, it depends upon the extent to which a patient's clinical and laboratory evidence is typical of MS. Other diseases usually have atypical features signaling they are not MS. Over-interpretation of the false-positive MRI is the most common mistake in misdiagnosing MS. The differential diagnosis of MS is not other white-matter diseases nor other diseases disseminated in time and space. Instead, the great mimicker of MS is psychiatric disease. On the rare occasions when another neurologic problem presents as MS, it will be a common condition such as migraine or stroke. Diagnoses of uncommon conditions are usually "false positives." Neurologists must learn to deal with psychiatric patients in a compassionate but firm manner and rely on primary care providers to help the well-being of those patients. Table 7 is a comprehensive list of 100 conditions that might mimic MS. While we believe this can be a valuable resource, most of these are rare conditions that will seldom be encountered.
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Differential Diagnosis of MS 
Rolak and Fleming
The Neurologist • Volume 13, Number 2, March 2007 It occurs in immune-compromised patients, the deficits are usually progressive rather than relapsing, the time course is short, and MRI lesions are generally larger and more confluent. CSF PCR may be positive for JC virus, but brain biopsy may be necessary for the diagnosis.
The Neurologist • Volume 13, Number 2, March 2007 Usually a systemic infection including fever. Specific antibodies can be found in serum and in CSF.
Subacute sclerosing panencephalitis (SSPE)
Chronic CNS infection by measles virus, most common in childhood but rarely in young adults.
Progressing or relapsing neurologic deficits in a young patient, occasionally with MRI signal abnormalities and with oligoclonal bands in the CSF (which are directed against measles antigens). Can cause diplopia, myelopathy, and other CNS deficits, occasionally with signal changes on MRI.
Low blood folate levels, as well as abnormal methylmalonic acid homocysteine.
Celiac disease (gluten sensitivity or sprue)
An immune disease with many autoantibodies, including an immune response to ingested gluten, as well as antigliadin, antiendomysial, and antitransglutaminase antibodies, often causing small-bowel malabsorption, as well as occasional relapsing neurologic deficits.
Ataxia and brainstem signs are common, as are periventricular white-matter lesions on MRI.
Antibody testing is now available for antigliadin antibodies. More than 90% or patients are HLA-DQ2. Spinal fluid is normal.
Amyotrophic lateral sclerosis (ALS)
Acquired upper and lower motor neuron disease causing progressive motor deficits.
Can especially resemble primary progressive MS, with a progressive myelopathy.
MRI and CSF will be normal. EMG will show peripheral nervous system abnormalities of denervation. 51. Primary lateral sclerosis Progressive upper motor neuron degenerative disease causing upper motor neuron (bulbar and spinal) deficits.
Especially resembles primary progressive MS, with a chronic progressive myelopathy.
VER, MRI, and CSF should be normal.
Adrenoleukodystrophy and adrenomyeloneuropathy
An X-linked genetic defect of a transporter protein, causing peroxisome dysfunction and an excess of very-long-chain fatty acids.
Adult forms commonly cause progressive paraparesis and ataxia, usually with confluent posterior white-matter changes on MRI. Female carriers may present with mild disease also.
Serum testing will show high levels of very-long-chain fatty acids. The ACTH stimulation test usually shows impaired adrenal function.
Metachromatic leukodystrophy
An autosomal recessive deficiency of arylsulfatase A.
May cause myelopathy and ataxia, with symmetric diffuse signal abnormalities on MRI.
Blood arylsulfatase A levels are low. Abnormal metabolism can be confirmed by study of cultured fibroblasts obtained by biopsy. DNA testing is now available.
Krabbe globoid cell leukodystrophy
Autosomal recessive deficiency of galactocerebroside ␤-galactosidase generally seen in infancy but rarely in young adults.
May cause paraparesis and visual symptoms in young patients, with confluent periventricular MRI signal abnormalities.
Patients have accompanying neuropathy, easily detected on nerve conduction testing. DNA testing is now available.
Fabry disease
An X-linked deficiency of the lysosomal enzyme ␣-galactosidase causing accumulation of ceramide trihexosidase in endothelium and smooth muscle cells. It is often of adult onset and can cause renal disease and angiokeratomas on the skin.
It causes recurrent strokes and thus focal neurologic findings in a young person with MRI signal abnormalities.
Patients may have skin lesions, corneal opacities, and renal disease. CSF will be normal. DNA testing and blood ␣-galactosidase levels are available.
Adult-onset autosomal dominant leukodystrophy
An autosomal-dominant leukodystrophy presenting in adulthood, causing motor and cerebellar deficits, usually with prominent autonomic dysfunction. The genetic defect is unknown.
Especially resembles primary progressive MS, with chronic upper motor neuron and cerebellar deficits accompanied by confluent white-matter lesions on MRI and occasionally IgG abnormalities in the CSF.
Family history with autosomaldominant inheritance. Automatic involvement is also prominent early.
Organic acidemias
Autosomal-recessive diseases usually seen in childhood but occasionally in adults.
May cause spasticity, ataxia, and optic atrophy in young adults.
MRI is usually normal, as is CSF.
May have a positive family history. Urinary organic acid screening will be abnormal. 58. Spinocerebellar ataxias Nearly 2 dozen diseases have been described with autosomal dominant progressive ataxia and gait disturbances, some due to triplet repeats.
Progressive myelopathy and cerebellar deficits in a young person. Rarely, T2 lesions have been described on MRI.
Strong family history. CSF will be normal. DNA testing is commercially available for many of these syndromes. 
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The Neurologist • Volume 13, Number 2, March 2007 MRI scanning will show the mass at the base of the skull.
Cranial nerve palsies:
Bell palsy, abducens palsy, etc.
Isolated cranial neuropathy, often idiopathic, which can occur in young people.
Occasionally, MS can present as an isolated facial weakness, numbness, or diplopia.
No other neurologic signs or symptoms are present, and MRI and CSF should otherwise be normal.
Drugs
Multiple drugs are capable of affecting the nervous system, either as drugs of abuse (toluene, alcohol, cocaine) or as therapeutic agents (cyclosporine, phenytoin, etc).
A variety of neurologic signs and symptoms may appear as manifestations of drug toxicity. Many drugs also produce whitematter changes on the MRI scan.
Unfortunately, a history of drug exposure is often difficult to obtain. Symptoms are usually not relapsing and remitting unless the drug exposure continues. CSF should be normal.
Environmental toxins
Many toxins can cause neurologic damage, including carbon monoxide, heavy metals, and organic solvents.
Neurologic abnormalities often are accompanied by white-matter changes on the MRI scan.
Exposure to toxins is usually apparent. Symptoms will not be progressive or relapsing if exposure has ceased. CSF should be normal.
Periventricular leukomalacia
Periventricular white-matter necrosis occurring in neonates, but often not symptomatic until adulthood.
May be associated with a variety of neurologic symptoms, and the MRI will show periventricular white matter lesions.
Symptoms are usually not relapsing or remitting. CSF should be normal.
Migratory sensory neuritis
Controversial entity of "sensory neuritis" causing patchy relapsing areas of numbness and paresthesias, presumably due to peripheral nerve dysfunction.
Multifocal relapsing sensory symptoms, often in a young person.
Deficits are purely subjective (sensory) with no motor or other findings. MRI and CSF will be normal. 97. Chronic fatigue syndrome and fibromyalgia Syndrome of chronic diffuse muscular pain and chronic fatigue, often with other somatic symptoms as well.
May report many neurologic symptoms that can mimic MS in a similar population (young women).
Neurological examination is objectively normal. Difficulties arise when the MRI shows "nonspecific" abnormalities, but MRI, CSF and VERs should be normal.
Myasthenia gravis
Autoimmune disorder producing antibodies against the acetylcholine receptor post synaptically on the muscle.
Can cause fluctuating weakness and diplopia, especially in young women.
Deficits are confined to weakness and fatigability in the motor system. MRI, CSF and VER will be normal. Perfectly normal people occasionally report that they experience focal, sometimes relapsing, neurologic symptoms identical to those that can be seen in MS.
Physical examination and laboratory tests will all be within normal limits.
